Inactive Instrument

Biofermin Pharmaceutical Co., Ltd.

4517

JP3799800002

Biofermin Pharmaceutical Co., Ltd.(TSE:4517) added to S&P Global BMI Index

September 19, 2016 at 05:00 am

Latest news about Biofermin Pharmaceutical Co., Ltd.

Taisho Pharmaceutical Holdings Co., Ltd. completed the acquisition of remaining 37% stake in Biofermin Pharmaceutical Co., Ltd. from a group of sellers.	26/07/21	CI
Taisho Pharmaceutical Holdings Co., Ltd. executed a share exchange agreement to acquire remaining 37% stake in Biofermin Pharmaceutical Co., Ltd. from a group of sellers for ¥14.8 billion.	13/05/21	CI
Biofermin Pharmaceutical Co., Ltd.(TSE:4517) dropped from S&P Global BMI Index	18/09/17	CI
Taisho and Takeda Terminate Agreement on the Distribution of Biofermin Pharmaceutical's OTC Drugs and Quasi-Drugs	01/02/17	CI
Biofermin Pharmaceutical Co., Ltd.(TSE:4517) added to S&P Global BMI Index	19/09/16	CI
Biofermin Pharmaceutical Co., Ltd.(TSE:4517) dropped from S&P Global BMI Index	21/09/15	CI
Takeda Pharmaceutical Company Limited and Taisho Pharmaceutical Co., Ltd. Agrees Conduct Domestic Transactions in Relation to Sale of Products Manufactured by Biofermin Pharmaceutical	31/07/13	CI
Taisho Pharmaceutical Co., Ltd. entered into a share purchase arrangement to acquire an additional 8.14% stake in Biofermin Pharmaceutical Co., Ltd. from Takeda Pharmaceutical Company Limited.	31/07/13	CI
Biofermin Pharmaceutical Co., Ltd.(TSE:4517) added to Japan TOPIX Index	25/07/13	CI

Chart Biofermin Pharmaceutical Co., Ltd.

Duration

Period

Chart Biofermin Pharmaceutical Co., Ltd.

More charts

BIOFERMIN PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals, quasi-drugs and food products. Its products include constipating agent, anti-diarrheal agent, stomachic and digestion tablets, vitamin C (VC), laxative, food raw materials and veterinary drugs. Additionally, the Company offers its products to both domestic and overseas markets.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B
PFIZER, INC.	-0.45%	162B

Other Pharmaceuticals